Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Strategic Asset Allocation Index
Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Strategic Asset Allocation Index of 3.2% as of December 2022. Strategic assets (PP&E of $150.82K plus long-term investments of $-) total $150.82K, measured against net assets of $4.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Lipella Pharmaceuticals Inc. Common Stoc (LIPO) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Lipella Pharmaceuticals Inc. Common Stock Strategic Asset Allocation Index (2020–2022)
This chart shows how Lipella Pharmaceuticals Inc. Common Stock's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 3.2%, representing strategic assets of $150.82K against net assets of $4.68 Million USD. See Lipella Pharmaceuticals Inc. Common Stoc (LIPO) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Lipella Pharmaceuticals Inc. Common Stock (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Lipella Pharmaceuticals Inc. Common Stock from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Lipella Pharmaceuticals Inc. Common Stoc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.2% | $150.82K | $150.82K | $- | $4.68 Million | ▼ -11.2 pp |
| 2021 | 14.4% | $204.80K | $204.80K | $- | $1.42 Million | ▼ -40.8 pp |
| 2020 | 55.2% | $255.59K | $255.59K | $- | $463.32K | — |